Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab – a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2025-09-01
DOI
https://doi.org/10.1136/bmjopen-2024-097802
Citations
3
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
3.14
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab – a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)

Alexander Reichart, Dirk Jäger, Christoph Springfeld, Leonie Jochheim et al.
3 citations
BMJ Open
Cancer Immunotherapy and Biomarkers
3.14
article

Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab – a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)

Alexander Reichart, Dirk Jäger, Christoph Springfeld, Leonie Jochheim, Patrick Michl, Michael T. Dill, Pavlos Missios, Conrad Rauber, Lukas D. Sauer, Thomas J. Ettrich, Anastasia Tsakmaklis, Peter Schirmacher, Raphael Mohr, Arne Kandulski, Maria J. G. T. Vehreschild, María Paula Roberti, Anja Sander, Andreas Teufel, Dirk Waldschmidt
article en
3 citations

Abstract

No abstract available for this paper.
BMJ OpenVol. 15(9)
Goethe University Frankfurt (DE), German Cancer Research Center (DE), University of Cologne (DE), Heidelberg University (DE), University Hospital Augsburg (DE), University Hospital Heidelberg (DE), University Hospital Regensburg (DE), National Center for Tumor Diseases (DE), German Center for Infection Research (DE), Hopp Children's Cancer Center Heidelberg (DE), University Children's Hospital Tübingen (DE), University Hospital Frankfurt (DE), University Hospital Cologne (DE), University Hospital Ulm (DE), University Medical Centre Mannheim (DE), University of Duisburg-Essen (DE), Charité - Universitätsmedizin Berlin (DE)
Openalex Percentile: Top 7%
Cancer Immunotherapy and Biomarkers
3.14
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.